glp-1 receptor antibody GLP1R (26196-1-AP) Frontiers | GLP-1 Receptor Agonists:

Another phase 2 trial using a higher dose of mazdutide for obesity (9 mg) is currently ongoing with a press release revealing a placebo-adjusted WL of 15.4% after 24 weeks [71]

These new treatment possibilities for clinicians, coupled with an increase in industry marketing and patients personal needs, have led to an explosion of prescriptions for these drugs especially in Western countries [9]

As research into GLP-1 medications continues to evolve, scientists may gain a better understanding of how these drugs influence alcohol consumption, cravings, and recovery

Find a clinic near you to get started What is a GLP-1 medication